This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Majoros, L. Articles by Szabó, B. Search for Related Content PubMed PubMed Citation Articles by Majoros, L. Articles by Szabó, B.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2003, p. 5250-5253, Vol. 41, No. 11
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.11.5250-5253.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Restriction Enzyme Analysis of Ribosomal DNA Shows that Candida inconspicua Clinical Isolates Can Be Misidentified as Candida norvegensis with Traditional Diagnostic Procedures

Department of Medical Microbiology,¹ 1st Department of Surgery,³ Department of Pulmonology,⁴ 3rd Department of Internal Medicine, Medical and Health Science Center, University of Debrecen, Debrecen,⁵ Department of Microbiology and Biotechnology, Faculty of Food Science, St. István University, Budapest, Hungary²

Received 20 February 2003/ Returned for modification 24 April 2003/ Accepted 28 July 2003

We identified 29 yeast isolates from 22 patients using the API ID32C panel. Twenty-eight of these isolates were Candida norvegensis and one was C. inconspicua. Although C. norvegensis is considered a pseudohypha-producing species, only one isolate produced pseudohyphae. Restriction enzyme analysis of PCR-amplified ribosomal DNA with four different enzymes proved that all isolates were C. inconspicua.

This article has been cited by other articles:

• Szabo, Z., Toth, B., Kovacs, M., Kardos, G., Maraz, A., Rozgonyi, F., Majoros, L. (2008). Evaluation of the New Micronaut-Candida System Compared to the API ID32C Method for Yeast Identification. J. Clin. Microbiol. 46: 1824-1825 [Abstract] [Full Text]  
• Soczo, G., Kardos, G., McNicholas, P. M., Balogh, E., Gergely, L., Varga, I., Kelentey, B., Majoros, L. (2007). Correlation of posaconazole minimum fungicidal concentration and time kill test against nine Candida species. J Antimicrob Chemother 60: 1004-1009 [Abstract] [Full Text]  
• Leaw, S. N., Chang, H. C., Barton, R., Bouchara, J.-P., Chang, T. C. (2007). Identification of Medically Important Candida and Non-Candida Yeast Species by an Oligonucleotide Array. J. Clin. Microbiol. 45: 2220-2229 [Abstract] [Full Text]  
• Pfaller, M. A., Diekema, D. J. (2007). Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem. Clin. Microbiol. Rev. 20: 133-163 [Abstract] [Full Text]  
• Leaw, S. N., Chang, H. C., Sun, H. F., Barton, R., Bouchara, J.-P., Chang, T. C. (2006). Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions.. J. Clin. Microbiol. 44: 693-699 [Abstract] [Full Text]  
• Majoros, L., Kardos, G., Szabo, B., Sipiczki, M. (2005). Caspofungin Susceptibility Testing of Candida inconspicua: Correlation of Different Methods with the Minimal Fungicidal Concentration. Antimicrob. Agents Chemother. 49: 3486-3488 [Abstract] [Full Text]  
• Majoros, L., Kardos, G., Feiszt, P., Szabo, B. (2005). Efficacy of amphotericin B and flucytosine against fluconazole-resistant Candida inconspicua clinical isolates. J Antimicrob Chemother 56: 253-254 [Full Text]  
• Majoros, L., Kardos, G., Szabo, B., Kovacs, M., Maraz, A. (2005). Fluconazole susceptibility testing of Candida inconspicua clinical isolates: comparison of four methods. J Antimicrob Chemother 55: 275-276 [Full Text]